Jan 31 (Reuters) - Hydration Pharmaceuticals Co Ltd (HPC) :
- Q4 FY23 NET SALES OF US$2.11M, SLIGHT DECREASE ON LAST QUARTER
- Q4 NET OPERATING EXPENDITURE DOWN 56% ON PCP TO $1.14 MILLION
- GROSS PROFIT UP 4% TO US$1.26M IN Q4 FY23
- TEMPORARY OUT OF STOCKS DURING QUARTER LED TO ESTIMATED UNFULFILLED ORDERS OF US$0.6M
- EXPECTS SWIFT RECOVERY FROM TEMPORARY ISSUE, HAS GOT SEVERAL SHIPMENTS TO IMPROVE SITUATION
- HYDRATION PHARMACEUTICALS SEES ADDITIONAL SALES FROM NEW SHIPMENTS DURING CURRENT QUARTER
News: HPC Hydration Pharmaceuticals Announces Q4 FY23 Net Sales Of US$2.11 Mln
Add HPC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.744M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 142428 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 444444 | 1 |
View Market Depth
| Last trade - 16.12pm 11/07/2024 (20 minute delay) ? |
| HPC (ASX) Chart |
Day chart unavailable